Brief: Zynerba Pharmaceuticals Reports Q2 Loss Per Share Of $0.25
Aug 9 (Reuters) - Zynerba Pharmaceuticals Inc ZYNE.O :
* ZYNERBA PHARMACEUTICALS REPORTS SECOND QUARTER 2021
FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
* Q2 LOSS PER SHARE $0.25
* Q2 EARNINGS PER SHARE ESTIMATE $-0.24 -- REFINITIV IBES
DATA
* ZYNERBA PHARMA - BELIEVES CASH AND CASH EQUIVALENTS AS OF
JUNE
30, 2021 SUFFICIENT TO FUND OPERATIONS AND CAPITAL REQUIREMENTS
WELL INTO H1 OF 2024
Source text for Eikon: ID:nGNXcl2XR
Further company coverage: ZYNE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zynerba Pharmaceuticals
See all newsBrief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary